Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study) (HDL Proteomics)

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT00880178
First received: April 10, 2009
Last updated: December 18, 2012
Last verified: December 2012